Zain Khalpey/LinkedIn
Dec 19, 2025, 09:24
Zain Khalpey on A New Study Linking Low-dose Aspirin to Reduced Cancer Spread
Zain Khalpey, Adjunct Assistant Professor of Surgery at Columbia University Irving Medical Center, shared on LinkedIn:
”A paper in The New England Journal of Medicine outlines a mechanism by which low-dose aspirin may reduce cancer spread, particularly in colorectal cancer and in individuals with certain mutations or CHIP.
By lowering platelet activation and thromboxane A2 signaling, aspirin helps release T cells from immune suppression and supports antimetastatic immunity.
Follow Zain Khalpey for more on Ai and Healthcare.”
Read the full article in NEJM.
Article: Understanding How Aspirin Prevents Metastasis
Authors: Ruth E. Langley, John Burn
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 10, 2026, 12:36Amitabh Kulkarni: What Parents Need to Know About Iron Deficiency Anemia in Children
-
Mar 10, 2026, 12:23Bastu Odoka: The Laboratory’s Role in Preventing RhD Disease
-
Mar 10, 2026, 12:22Kalyan Roy: Rediscovering Cold-Stored Platelets in Modern Transfusion Medicine
-
Mar 10, 2026, 04:15Abdul Mannan: NK Cell ALL and the Diagnostic Challenge of a Provisional Entity:
-
Mar 9, 2026, 16:51Melanie Daniel: Exploring Bleeding Complications in Patients with LVADs
-
Mar 9, 2026, 16:30Mohamed Sikkander Abdul Razak: Recent Breakthroughs in Stem Cell Therapy for Diabetes Treatment
-
Mar 9, 2026, 16:28Augustina Isioma Ikusemoro: Is Blood Really Affordable?
-
Mar 9, 2026, 16:26Todd Maderis: Great Conversation on Effective Treatment of Chronic Infections
-
Mar 9, 2026, 16:25Denise Braendgaard: How Partnership is Turning Ambition Into Action